FDA 510k Clearance

Topic

Official medical device regulatory clearance granted by the FDA, which Whoop obtained through clinical trials for its wrist-based ECG and AFib detection feature.


First Mentioned

11/1/2026, 5:22:55 AM

Last Updated

11/1/2026, 5:29:22 AM

Research Retrieved

11/1/2026, 5:29:22 AM

Summary

FDA 510(k) clearance is a regulatory process managed by the U.S. Food and Drug Administration (FDA) that allows medical devices to be marketed. This process is part of the Federal Food, Drug, and Cosmetic Act, which grants the FDA authority over the safety of various products. For instance, Whoop, a company specializing in wearables, underwent the FDA 510(k) clearance process to obtain approval for its medical-grade wrist ECG feature. However, Whoop also encountered regulatory challenges with the FDA regarding its cuffless Blood Pressure Insights feature, which was initially launched as a wellness application. This situation ultimately led the FDA to update its guidelines to acknowledge wellness applications for blood pressure monitoring.

Research Data
Extracted Attributes
    Federal Food, Drug, and Cosmetic Act

    The Federal Food, Drug, and Cosmetic Act (abbreviated as FFDCA, FDCA, or FD&C) is a set of laws passed by the United States Congress in 1938 giving authority to the Food and Drug Administration (FDA) to oversee the safety of food, drugs, medical devices, and cosmetics. The FDA's principal representative with members of congress during its drafting was Charles W. Crawford. A principal author of this law was Royal S. Copeland, a three-term U.S. senator from New York. In 1968, the Electronic Product Radiation Control provisions were added to the FD&C. Also in that year the FDA formed the Drug Efficacy Study Implementation (DESI) to incorporate into FD&C regulations the recommendations from a National Academy of Sciences investigation of effectiveness of previously marketed drugs. The act has been amended many times, most recently to add requirements about bioterrorism preparations. The introduction of this act was influenced by the death of more than 100 patients due to elixir sulfanilamide, a sulfanilamide medication where the toxic solvent diethylene glycol was used to dissolve the drug and make a liquid form. It replaced the earlier Pure Food and Drug Act of 1906.

    Web Search Results
    • 510k Clearance Explained: What FDA 510(k) Means For Devices

      ## What Is FDA 510(k) Clearance? FDA 510(k) clearance is a premarket authorization that lets a medical device be legally marketed in the United States after the manufacturer demonstrates it is “substantially equivalent” to a device already on the market (a predicate). Named after Section 510(k) of the Federal Food, Drug, and Cosmetic Act, it is the pathway most moderate-risk (Class II) diagnostic and therapeutic devices follow. HealthWright Technologies distributes medical devices built on FDA-cleared components. Clearance applies at the component level rather than to a bundled system, and some items we supply are Class I exempt and carry no clearance of their own. We provide the clearance documentation we hold on request. [...] In practical terms, FDA 510(k) clearance tells a physician that the FDA has reviewed the device, compared it to a legally marketed predicate, and agreed it is at least as safe and effective for its intended use. You can verify the clearance status of any device through the FDA 510(k) Premarket Notification Database by searching the device name, manufacturer, or K-number. [...] FDA 510(k) clearance is a regulatory determination and is separate from coverage decisions, though using FDA-cleared devices helps satisfy facility accreditation requirements. Reimbursement is addressed under Medicare Local Coverage Determinations when medical necessity is documented, and it depends on the specific test and the documentation in the record. Confirm coverage with your Medicare Administrative Contractor’s LCD, and contact us if you need the regulatory records that support your billing and accreditation files.

    • FDA 510k Clearance Services For Medical Device and IVDs

      ### Download 510k Brochure ## FDA 510k Clearance FDA 510k is a file containing sufficient information about a medical devices to demonstrate that the device is at least as safe and effective as legally marketed devices that are not subjected to PMA. Organizations planning to launch Class I, Class II, and Class III medical devices in the United States intended for human use must submit a 510k if pre-market approval is not required. Most class 1 devices are exempt from 510k requirements. During the review of the file, if the FDA finds the device to be substantially equivalent, it will grant the FDA 510k clearance for medical devices with a ‘(k)’ number. [...] The usual FDA 510(k) clearance process includes the following steps: First, determine the classification of your device and if it is a 510(k) device (most Class II devices are). Next, identify a predicate device that is legally marketed for the same intended use. Perform a full equivalence comparison. Collect appropriate supporting data such as performance testing, biocompatibility, software documentation or clinical data Provide a submission in the required FDA format – all relevant sections (device description, indications for use, predicate comparison, testing summaries, labelling). Pre-Submission meeting with FDA (if desired) to discuss strategy before filing. [...] A premarket submission to FDA 510(k) clearance is required before most Class II (moderate risk) medical devices can be sold in the US. To show safety and efficacy without starting from scratch, manufacturers must show their product is “substantially equivalent” to a predicate device that is already on the market. Substantial equivalency refers to the equipment having the same intended use and either having the same technological features or, in the event that there are changes, such differences do not raise new safety concerns.

    • What is the FDA 510(k)? | Glossary

      Compliance & Regulatory: MedTech FDA Clearance A 510(k) is a premarket submission made to the FDA. It is called a 510(k) because it refers to that section of the Food, Drug and Cosmetic Act. It is the regulatory pathway mostly utilized for Class II devices that hope to be substantially equivalent to another device which is currently legally marketed. If FDA agrees that the device is substantially equivalent, then it may be marketed immediately without the need for a premarket approval (PMA) submission. FDA generally does not require clinical data in 510(k) submissions, but in some cases they may request clinical data to confirm substantial equivalency. This does not mean that you shouldn’t think about clinical data for reimbursement or adoption purposes.

    • 510(k) Submission Guide: FDA Clearance Explained

      Clearance not only impacts time-to-market but also supports market access, reimbursement, and commercial strategy. In essence, a well-prepared 510(k) submission establishes regulatory confidence, improves credibility with payers and distributors, and lays the foundation for successful device commercialization. ## What Is a 510(k) Submission? A 510(k) submission is an FDA premarket notification that demonstrates a device is substantially equivalent to a predicate device already legally on the market. Clearance is required for most Class II devices and some Class I devices before they can be sold in the United States. [...] Substantial equivalence means the new device has the same intended use and technological characteristics (or any differences do not raise new questions of safety or effectiveness) compared with the predicate device. ## Why 510(k) Clearance Matters 510(k) clearance is critical for several reasons. First, it allows legal marketing of medical devices in the U.S., ensuring compliance with federal regulations. Beyond regulatory approval, clearance provides credibility with payers, distributors, and healthcare providers, which can directly impact adoption and reimbursement opportunities. [...] They allow companies to: Track FDA guidance updates in real time Pre-populate forms and organize technical documentation Automate submission tracking and compliance checks Reduce errors and accelerate review timelines Support cross-functional teams in compiling evidence and testing data Automation and intelligence platforms, such as RegDesk, can streamline the entire 510(k) workflow, from preparation to clearance, saving both time and resources. ## Conclusion 510(k) clearance is essential for bringing medical devices to market efficiently and safely. Achieving clearance requires careful planning, thorough documentation, and cross-functional alignment between regulatory, clinical, and manufacturing teams.

    • FDA 510(k) Clearance - Dangerous Fast-Track Approval Process

      If a company can prove its device is “substantially equivalent” to another already on the market, it can forego clinical trials and testing, saving time and money. Unlike the more rigorous PMA standard, which is to reasonably ensure safety and effectiveness, the 510(k) standard is to determine whether a device is substantially equivalent to a legally marketed device. In other words, when the FDA clears a device through 510(k), it is not examining if the product is safe or effective for use in patients. It is just agreeing with the maker’s claim that the device is similar to another device already on the market. Fact FDA clearance through the 510(k) process means the agency is in agreement with the manufacturer that a medical device is similar to a previously approved product. [...] (888) 645-1617Call Now click to open search box Brought To You By The Wilson Firm LLP Home FDA 510(k) Clearance Process # FDA 510(k) Clearance Process The vast majority of medical devices on the U.S. market were given the government’s green light in a process known as the 510(k), which requires no clinical trials and very little oversight. Patient advocacy groups and government watchdogs have been highly critical of the system, which they say lets far too many dangerous devices on the market, injuring and killing unsuspecting patients. Michelle Llamas, Senior Content Writer Written by Michelle Llamas, BCPA Medically reviewed by Mireille Hobeika, Pharm.D. Last update: December 11, 2025 Est. Read Time: 9 min read [...] In 2018, FDA began looking into improving the 510(k) clearance pathway. However, it hasn’t removed it. In November 2022, the agency reported it had cleared 27 products through the 510(k) for which it had supporting documentation. ## Speeding up the Process Jeffrey Shuren, director of the Center for Devices and Radiological Health, told Congress in March 2017 that the agency has made progress in shortening the amount of time it takes to grant 510(k) clearance. In 2010, he said, the average time for a 510(k) decision was 150 days. By 2015, the average was 133 days, a decrease of 11 percent. Shuren said the agency has sped up the review process “without compromising the agency’s high standards.”